Introduction Idiopathic Pulmonary Fibrosis (IPF) is a progressive and often fatal interstitial lung disease marked by chronic fibrosis and inflammation of lung tissue. IPF remains a significant therapeutic challenge despite the availability of antifibrotic agents like pirfenidone and nintedanib. Recent attention has turned toward inflammation-modulating and immunoregulatory … [Read more...]
Interstitial Lung Disease and Progressive Pulmonary Fibrosis
Disorders characterized by inflammation or scarring in the lungs may be the most complicated area within lung medicine. Not only are the names confusing but they have repeatedly changed over the past 50 years. Furthermore, many of the early studies describing the natural history of one disease or another have turned out to be inaccurate. To make … [Read more...]